Jiangnan Zhang
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Recent advances in the design of small molecules targeting human ClpP.
Journal: Future medicinal chemistry
Published: September 08, 2025
Discovery of potent ClpX modulators with pronounced antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
Journal: European journal of medicinal chemistry
Published: August 19, 2025
Peptide-based rigid nanorod-reinforced gelatin methacryloyl hydrogels for osteochondral regeneration and additive manufacturing.
Journal: Nature communications
Published: March 29, 2025
Discovery of 5-(Piperidin-4-yl)-1,2,4-oxadiazole Derivatives as a New Class of Human Caseinolytic Protease P Agonists for the Treatment of Hepatocellular Carcinoma.
Journal: Journal of medicinal chemistry
Published: June 21, 2024
Integrating computational and experimental approaches in discovery and validation of MmpL3 pore domain inhibitors for specific labelling of Mycobacterium tuberculosis.
Journal: International journal of biological macromolecules
Published: June 17, 2024
Discovery and Optimization of Novel SaFabI Inhibitors as Specific Therapeutic Agents for MRSA Infection.
Journal: Journal of medicinal chemistry
Published: June 07, 2024
Chemical activation of mitochondrial ClpP to modulate energy metabolism of CD4+ T cell for inflammatory bowel diseases treatment.
Journal: Cell reports. Medicine
Published: April 23, 2024
Rational Design of a Novel Class of Human ClpP Agonists through a Ring-Opening Strategy with Enhanced Antileukemia Activity.
Journal: Journal of medicinal chemistry
Published: April 15, 2024
Discovery of a Novel Series of Homo sapiens Caseinolytic Protease P Agonists for Colorectal Adenocarcinoma Treatment via ATF3-Dependent Integrated Stress Response.
Journal: Journal of medicinal chemistry
Published: February 08, 2024
Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
Journal: European journal of medicinal chemistry
Published: January 10, 2024
Discovery of a Novel Series of Imipridone Compounds as Homo sapiens Caseinolytic Protease P Agonists with Potent Antitumor Activities In Vitro and In Vivo.
Journal: Journal of medicinal chemistry
Published: May 24, 2022
IMP075 targeting ClpP for colon cancer therapy in vivo and in vitro.
Journal: Biochemical pharmacology
Published: May 08, 2022
Last Updated: 09/26/2026